DermTech (DMTK) Financials

$0.04

$-0.01 (-12.05%)

As on 29-Aug-2024 09:30EDT

Market cap

$3 Mln

Revenue (TTM)

$16 Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-13
Operating Revenue	15.66	15.30	14.52	11.84	5.89	3.36
Cost of Revenue	14.33	15.02	13.87	10.56	5.98	3.30
Gross Profit	1.33	0.28	0.65	1.27	-0.10	0.06
Operating Expenses	92.24	104.02	118.81	78.67	35.19	17.67
Operating Profit (EBIT)	-90.90	-103.74	-118.17	-77.40	-35.29	-17.61
Other Income	0.01	--	0.14	-1.09	--	--
Profit before Tax	-89.63	-100.89	-116.68	-78.34	-35.25	-19.69
Provision for Tax	0.78	--	-2.96	-1.36	-0.53	2.21
Profit after Tax (Net Income)	-89.63	-100.89	-113.72	-76.98	-34.72	-21.90
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-31.36	--	-116.68	-78.34	-35.25	-19.69

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-13
Shareholder's Funds	39.99	57.18	132.35	229.70	63.49	12.49
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	50.46	51.31	54.09	6.43	0.87	5.03
Current Liabilities	12.52	13.45	15.64	12.18	5.43	5.72
Total Liabilities	115.49	121.93	202.08	248.31	69.78	18.21

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-13
Non-Current Assets	58.77	60.18	66.04	15.49	2.90	1.06
Current Assets	44.20	61.75	136.04	232.82	66.88	17.15
Total Assets	115.49	121.93	202.08	248.31	69.78	18.21
Total Debt*	53.67	54.39	55.83	7.86	0.34	--
Net Current Assets	31.68	48.31	120.40	220.64	61.46	11.43

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-13
Cash From Operating Activities	--	-76.98	-95.26	-62.11	-28.68	-17.79
Cash Flow from Investing Activities	--	--	-4.32	-12.51	-41.34	-0.21
Cash from Financing Activities	--	6.08	0.92	230.28	78.90	28.62
Net Cash Inflow / Outflow	--	--	-98.66	155.66	8.87	--

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-13
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-13
ROCE (%)	--	--	-67.31	-53.42	-51.08	-91.00
ROE (%)	--	-158.55	-106.46	-62.82	-52.51	-91.40
ROA (%)	--	-58.06	-62.28	-50.50	-48.40	-78.92
EBIT Margin (%)	--	-580.39	-678.21	-813.92	-653.81	-599.64
Net Margin (%)	--	-571.97	-659.57	-775.76	-716.06	-590.03
Cash Profit Margin (%)	--	0.00	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-13
Revenue Growth (%)	--	9.71	0.05	0.23	1.01	0.75
EBIT Growth (%)	--	24.25	12.21	-52.67	-119.33	-100.45
Net Profit Growth (%)	--	21.57	11.28	-47.73	-121.69	-58.54
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-13
Price / Earnings	--	--	--	--	--	--
Price / Book Value	--	0.02	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	--	-0.21	0.02	0.59	2.85	1.82
Close Price ($)	--	0.70	1.75	1.77	15.80	32.44
High Price ($)	--	4.67	6.44	17.68	84.49	37.37
Low Price ($)	--	0.62	1.12	1.55	15.15	8.69
Market Cap ($ Cr)	--	3.29	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-13
Debt to Equity	--	--	0.95	0.42	0.03	0.01
Short term debt to equity ratio	--	0.08	0.05	0.01	0.01	0.00
Current Ratio	--	3.53	4.59	8.70	19.11	12.33
Quick Ratio	--	3.46	4.52	8.59	19.07	12.31
Interest Coverage	--	-57.28	--	-88.12	-512.57	-882.23

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-13
Debtors to sales (%)	--	15.94	16.89	28.74	32.50	25.15
Asset Turnover	--	0.10	0.09	0.06	0.07	0.13
Receivable days	--	--	80.66	100.87	82.18	67.03
Inventory Days	--	--	33.57	29.45	10.10	4.24
Payable days	--	--	47.46	69.77	76.98	97.16
Cash Conversion Cycle	--	--	66.78	60.56	15.29	-25.89

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.